Omada Health is trading 5.6% down at $22.01, with no clear immediate catalyst identified.
- No company-specific announcement, earnings release, guidance change, or analyst action was identified for September 3, 2026; the latest listed release remains its August 6 second-quarter results and CEO-transition announcement.
- The decline diverges from broader markets and healthcare, which are higher.
- BlackRock’s recently disclosed stake was positive but appears stale and does not explain today’s selling.